Back to search

National and Kapodistrian University of Athens

Μελέτη των επιδράσεων της Μεσογειακής διατροφής, της δίαιτας DASH και του περιορισμού άλατος στα επίπεδα της αρτηριακής πίεσης και στους καρδιομεταβολικούς παράγοντες κινδύνου στην προ-υπέρταση και στην αρτηριακή υπέρταση σταδίου 1 σε χρονικό διάστημα 3 μηνών

Abstract

dc:description

Introduction: Lifestyle interventions are recommended as the first-line treatment to control high-normal blood pressure (BP) and uncomplicated grade 1 hypertension, as well as cardiometabolic risk factors. However, studies directly comparing the effects of the Dietary Approaches to Stop Hypertension (DASH) vs. the Mediterranean diet (MedDiet) on a salt restriction background are currently lacking. Aim: The aim of the DASH-MedDiet (Dietary Approaches to Stop Hypertension-Mediterranean Diet) randomized controlled clinical trial was to assess the BP and the cardiometabolic effects of a 3-month intensive dietary intervention implementing salt restriction either alone or in the context of the DASH, and the MedDiet compared to no/minimal intervention in never drug-treated adults with high-normal BP or grade 1 hypertension. Methods: After eligibility assessment, enrolled patients were randomized to one of the four study groups: the control group (CG), the salt restriction group (SRG), the DASH diet combined with salt restriction group (DDG) or the MedDiet combined with salt restriction group (MDG). After randomization, all patients were followed monthly for 3 months in individual sessions. Patients in the CG received general oral advice on dietary principles for BP control, while patients in the three intervention groups participated in an intensive 3-month dietary intervention. Patients in the SRG received an illustrated booklet and intensive counselling to be gradually trained to increase adherence to salt restriction and achieve the goal of 5g/day. Each patient in the DDG and the MDG received a more extensive illustrated booklet according to the assigned diet, an individualized dietary plan which incorporated the principles of the DASH or the MedDiet and intensive counselling to be gradually trained to increase adherence both to salt restriction and the assigned dietary pattern and achieve the recommended goals. All patients were assessed in respect of anthropometric indices, dietary adherence, physical activity level, and office BP at baseline and during the three follow-up visits. In addition, ABPM collection of fasting blood samples and 24-hour urine samples, and clinical diagnosis of the metabolic syndrome were conducted at baseline and the end of the study. The primary outcome of the DASH-MedDiet study was the attained mean office systolic BP difference among the randomized arms at the end of the 3-month dietary intervention. Results: A total of 240 patients were enrolled in the four study groups with a 1:1:1:1 allocation. After randomization, 11 patients were excluded for certain reasons and 25 patients were lost to follow-up, while 85% of the patients completed the study. According to the intention-to-treat analysis, compared to the CG, systolic and diastolic office BP and 24h ambulatory systolic and diastolic BP were reduced in all intervention groups. In addition, a greater reduction in the mean office systolic BP was observed in the MDG compared to both the SRG and the DDG (MDG vs. SRG: MD = -7.5 mmHg, 95% CI: -9,8, -5,3 and vs. DDG: MD = -3.2 mmHg, 95% CI: -5,4, -1,0). During the 3-month evaluation, the DDG and the MDG did not differ concerning the office diastolic BP and the 24h ambulatory systolic BP. However, both diets combined with salt restriction were more efficient in office BP-lowering compared to salt restriction alone. Moreover, compared to no/minimal intervention, the 3-month dietary intervention reduced total and LDL-cholesterol, fasting glucose, and HbA1c. Compared to the SRG, the DDG reduced HbA1c, while the MDG also reduced fasting glucose, total and LDL-cholesterol. At the end of the study, compared to the CG, the DDG and the MDG had 71% and 85%, respectively, lower odds of metabolic syndrome. However, compared to the SRG, only the MDG had 75% lower odds of metabolic syndrome. Conclusions: The 3-month dietary intervention of the DASH-MedDiet study had a meaningful effect on BP reduction and also improved patients’ cardiometabolic profile compared to no/ minimal intervention. The most important result of this study was that in this population the MedDiet was superior regarding office systolic BP reduction compared to the DASH diet. However, regarding office diastolic BP and 24h ambulatory systolic BP, as well as metabolic syndrome prevalence reduction, equal effectiveness was proved for the two diets. Therefore, dietary interventions including the adoption of a healthy, balanced diet combined with salt restriction are of great importance for public health, since they can be used as a realistic and effective alternative to drug treatment to manage increased blood pressure and improve cardiometabolic risk factors. Registration number: NCT05669404 clinicaltrials.gov/

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Filippou, Christina
  • Φιλίππου, Χριστίνα

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56510

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Filippou, Christina; Φιλίππου, Χριστίνα. Μελέτη των επιδράσεων της Μεσογειακής διατροφής, της δίαιτας DASH και του περιορισμού άλατος στα επίπεδα της αρτηριακής πίεσης και στους καρδιομεταβολικούς παράγοντες κινδύνου στην προ-υπέρταση και στην αρτηριακή υπέρταση σταδίου 1 σε χρονικό διάστημα 3 μηνών. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/56510